We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pre-market futures are up after two straight days of closing market indexes in the red. Q2 earnings season is in its final stages, the AI trade feels long in the tooth, and a pause on Canadian tariffs and relative quiet on the Middle Eastern front are helping the tide come in somewhat for stock buying.
Biggest among the gainers this morning is Moderna (MRNA - Free Report) , up +95% at this hour following a report regarding the efficacy of its intismeran vaccine, which met its primary goals in Phase 3 testing: preventing cancer in melanoma patients whose tumors had been surgically removed. Moderna’s partner/bank for this vaccine’s development is Merck (MRK - Free Report) , which is up +7% on the news.
Also, as this article gets typed, news from the U.S. Treasury has sent bonds yields notably lower and market indexes notably higher: it plans to double liquidity support buyback operations on longer-end securities (10-30 years). The current buyback position is $2 billion per operation; this will now become $4 billion. The 30-year bond has now dropped below +5.3%, the 10-year beneath +4.7% and the 2-year under +4.2%. Market indexes are now up triple digits a half hour ahead of the opening bell.
Morning Earnings Reports at a Glance: TGT, LOW & More
Target (TGT - Free Report) reported beats on both top and bottom lines this morning, with earnings of $2.46 per share on revenues of $26.54 billion up +7% and +1.6% from expectations, respectively. Guidance was raised going forward, with emphasis on the success of the retailer’s turnaround. Yet shares are selling off -1%, following +56% growth year to date.
Lowe’s (LOW - Free Report) posted mixed Q2 results this morning, outpacing estimates on earnings by +4.27% to $4.40 per share while revenues of $25.96 billion missed the Zacks consensus by -0.68% (though still up $2 billion from a year ago). The company continued the narrative from Home Depot’s earnings yesterday, which depicted a frozen housing market.
TJ Maxx, Marshall’s and HomeGoods parent The TJX Companies (TJX - Free Report) outperformed estimates this morning, with earnings of $1.22 per share surpassing the Zacks consensus by 4 cents on revenues of $15.18 billion, up +0.29% from expectations. A weaker outlook in the current quarter, however, saw investors sell shares -3.3% on the news.
Estee Lauder (EL - Free Report) shares are booming this morning — +12% — following its strong performance in fiscal Q4 this morning: earnings of $0.39 per share bettered the $0.32 anticipated, while revenues of $3.63 billion improved by +2.15% over expectations. Shares had been down -12.7% year to date, so the stock is back to breakeven.
What to Expect from the Stock Market Today
Of course, we’ll keep an eye on developments in the Strait of Hormuz and at the White House. This afternoon, we’ll see the Fed minutes from the latest Federal Open Market Committee (FOMC) meeting from last month. While the Fed kept interest rates steady at their 3.50-3.75% range, there were three dissenters who voted for a 25 basis-point increase.
In the first FOMC meeting with Fed Chair Kevin Warsh at the helm, we saw many changes afoot: no guidance in the Fed monetary policy statement nor in the press conference which followed. The minutes from that meeting, when they were announced, were detailed and expansive. We expect the minutiae to be tilled in today’s release, as well. Hopefully it will give us some of the answers the DC press pool had been looking for.
View the Zacks #1 Rank List
Image: Shutterstock
Bond Yields Open Notably Lower
Pre-market futures are up after two straight days of closing market indexes in the red. Q2 earnings season is in its final stages, the AI trade feels long in the tooth, and a pause on Canadian tariffs and relative quiet on the Middle Eastern front are helping the tide come in somewhat for stock buying.
Biggest among the gainers this morning is Moderna (MRNA - Free Report) , up +95% at this hour following a report regarding the efficacy of its intismeran vaccine, which met its primary goals in Phase 3 testing: preventing cancer in melanoma patients whose tumors had been surgically removed. Moderna’s partner/bank for this vaccine’s development is Merck (MRK - Free Report) , which is up +7% on the news.
Also, as this article gets typed, news from the U.S. Treasury has sent bonds yields notably lower and market indexes notably higher: it plans to double liquidity support buyback operations on longer-end securities (10-30 years). The current buyback position is $2 billion per operation; this will now become $4 billion. The 30-year bond has now dropped below +5.3%, the 10-year beneath +4.7% and the 2-year under +4.2%. Market indexes are now up triple digits a half hour ahead of the opening bell.
Morning Earnings Reports at a Glance: TGT, LOW & More
Target (TGT - Free Report) reported beats on both top and bottom lines this morning, with earnings of $2.46 per share on revenues of $26.54 billion up +7% and +1.6% from expectations, respectively. Guidance was raised going forward, with emphasis on the success of the retailer’s turnaround. Yet shares are selling off -1%, following +56% growth year to date.
Lowe’s (LOW - Free Report) posted mixed Q2 results this morning, outpacing estimates on earnings by +4.27% to $4.40 per share while revenues of $25.96 billion missed the Zacks consensus by -0.68% (though still up $2 billion from a year ago). The company continued the narrative from Home Depot’s earnings yesterday, which depicted a frozen housing market.
TJ Maxx, Marshall’s and HomeGoods parent The TJX Companies (TJX - Free Report) outperformed estimates this morning, with earnings of $1.22 per share surpassing the Zacks consensus by 4 cents on revenues of $15.18 billion, up +0.29% from expectations. A weaker outlook in the current quarter, however, saw investors sell shares -3.3% on the news.
Estee Lauder (EL - Free Report) shares are booming this morning — +12% — following its strong performance in fiscal Q4 this morning: earnings of $0.39 per share bettered the $0.32 anticipated, while revenues of $3.63 billion improved by +2.15% over expectations. Shares had been down -12.7% year to date, so the stock is back to breakeven.
What to Expect from the Stock Market Today
Of course, we’ll keep an eye on developments in the Strait of Hormuz and at the White House. This afternoon, we’ll see the Fed minutes from the latest Federal Open Market Committee (FOMC) meeting from last month. While the Fed kept interest rates steady at their 3.50-3.75% range, there were three dissenters who voted for a 25 basis-point increase.
In the first FOMC meeting with Fed Chair Kevin Warsh at the helm, we saw many changes afoot: no guidance in the Fed monetary policy statement nor in the press conference which followed. The minutes from that meeting, when they were announced, were detailed and expansive. We expect the minutiae to be tilled in today’s release, as well. Hopefully it will give us some of the answers the DC press pool had been looking for.